Marko Mihic
Impact in
-
- Diabetes Management and Research
- Diabetes Treatment and Management
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Pharmaceutical Science top 10%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
Papers in
-
- Diabetes Management and Research 4
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 2
- Diabetes Treatment and Management 2
- Diabetes, Cardiovascular Risks, and Lipoproteins 1
- Genetics 2
- Diabetes and associated disorders 2
- Co-authors
- Pankaj Modi (5 shared papers)Andrew Lewin (1 shared paper)Lawrence A. Leiter (1 shared paper)Robert M. Cohen (1 shared paper)Thomas M.S. Wolever (1 shared paper)David M. Nathan (1 shared paper)Carol Palmason (1 shared paper)Robert G. Josse (1 shared paper)
- Journals
- Diabetes Care (2 papers)Diabetes/Metabolism Research and Reviews (2 papers)Diabetes Technology & Therapeutics (1 paper)Diabetes Research and Clinical Practice (1 paper)Current Diabetes Reviews (1 paper)
- Partner nations
- CanadaUnited StatesFrance
In The Last Decade
Marko Mihic
8 papers receiving 317 citations
Peers
Comparison fields: 5 of 61
- Endocrinology, Diabetes and Metabolism 200
- Pharmaceutical Science 50
- Pharmacology 26
- Surgery 60
- Genetics 36
Countries citing papers authored by Marko Mihic
This map shows the geographic impact of Marko Mihic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marko Mihic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marko Mihic more than expected).
Fields of papers citing papers by Marko Mihic
This network shows the impact of papers produced by Marko Mihic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marko Mihic. The network helps show where Marko Mihic may publish in the future.
Co-authors
The 14 scholars most cited alongside Marko Mihic, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 134 | |
| 2 | 2002 | 76 | |
| 3 | 1985 | 64 | |
| 4 | 2004 | 26 | |
| 5 | 2004 | 24 | |
| 6 | 2008 | 11 | |
| 7 | Effect of trimethoprim-sulfamethoxazole on blood insulin and glucose concentrations of diabetics. | 1975 | 11 |
| 8 | 2000 | 1 |
About Marko Mihic
Marko Mihic is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics, Infectious Diseases, Neurology and Pharmaceutical Science, having authored 8 papers that have together received 347 indexed citations. Recurring topics across this work include Diabetes Management and Research (4 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (2 papers), Diabetes and associated disorders (2 papers), Diabetes Treatment and Management (2 papers), Pneumocystis jirovecii pneumonia detection and treatment (1 paper), HIV/AIDS drug development and treatment (1 paper), HIV-related health complications and treatments (1 paper) and Diabetes, Cardiovascular Risks, and Lipoproteins (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (200 citations), Pharmaceutical Science (50 citations), Pharmacology (26 citations), Surgery (60 citations) and Genetics (36 citations). Marko Mihic has collaborated with scholars based in Canada, United States and France. Frequent co-authors include Pankaj Modi, Andrew Lewin, Lawrence A. Leiter, Robert M. Cohen, Thomas M.S. Wolever, David M. Nathan, Carol Palmason, Robert G. Josse, Jean‐Louis Chiasson and B. S. Leibel. Their work appears in journals such as Diabetes Care, Diabetes/Metabolism Research and Reviews, Diabetes Technology & Therapeutics, Diabetes Research and Clinical Practice and Current Diabetes Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.